Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1200/week)
    • Manufacturing(600/week)
    • Energy(442/week)
    • Technology(1148/week)
    • Other Manufacturing(390/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Benzodiazepines

Jun 08, 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO® (Diazepam Nasal Spray)
May 04, 2020
Neurelis Announces That Intravail® Licensee, ARS Pharmaceuticals' Intranasal Epinephrine Product, Demonstrates Bioequivalent Exposure To Epinephrine Injectors
Mar 02, 2020
Neurelis Announces Commercial Availability of VALTOCO® (Diazepam Nasal Spray) for Seizure Cluster Rescue
Jan 13, 2020
Neurelis Announces FDA Approval for Seizure Rescue Treatment VALTOCO® (Diazepam Nasal Spray) that Incorporates the Science of Intravail® for Consistent and Reliable Absorption
Oct 15, 2019
Diazepam Market To Reach USD 1.27 Billion By 2026 | Reports And Data
Apr 29, 2019
Neurelis Announces Two Poster Presentations At The Annual Meeting Of The American Academy Of Neurology
Apr 22, 2019
Neurelis Announces Completion Of Senior Management Team Buildout To Support The Anticipated Commercial Launch Of VALTOCO(TM)
Mar 06, 2019
Okayama University Research: Inflammation in the Brain Enhances the Side-effects of Hypnotic Medication
Feb 25, 2019
Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Dec 20, 2018
Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters
Nov 29, 2018
Aquestive Therapeutics Launches SYMPAZAN(TM) (clobazam) Oral Film with Widespread U.S. Availability
Nov 02, 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Oct 23, 2018
Upsher-Smith Launches Generic Version Of Onfi® (clobazam), CIV In Tablet And Oral Suspension Dosage Forms
Oct 23, 2018
Are Anti-Anxiety Meds the Next Opioid Crisis? "BENZO FREE," a New Book by D E Foster, Reveals the Facts and Intimate Reality of this Developing Epidemic
Oct 23, 2018
Amneal Announces Approval and Launch of Clobazam Tablets and Clobazam Oral Suspension
Aug 31, 2018
Aquestive Therapeutics Announces Tentative FDA Approval for Sympazan(TM) (clobazam) Oral Film
Jan 25, 2018
CCHR: Another Celebrity Lost to Benzodiazepines and Opioids Mix
Jan 02, 2018
New Drug Testing Approach a Game-Changer for Benzodiazepine Abuse
Oct 17, 2017
Over 130,000 US Toddlers and Children Aged 0-5 Are Prescribed Addictive 'Anti-Anxiety' Drugs
Sep 26, 2017
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
  •  
  • Page 1
  • ››

Latest News

May 24, 2025

ATS Announces Settlement with EV Customer, Preliminary Fourth Quarter 2025 Results and Fourth Quarter...

May 24, 2025

HAFNIA LIMITED: Mandatory notification of trade by primary insider

May 24, 2025

U. S. Steel Statement on President Trump’s Leadership

May 24, 2025

Protolabs Announces Inducement Awards Under NYSE Rule 303A.08

May 24, 2025

You're Invited: Celebrate the Grand Re-Opening of the Dearborn Area Board of REALTORS® Association...

May 24, 2025

Huawei ICT Competition 2024-2025 Global Final Concludes: AI Empowers Education Transformation and ICT Talent...

May 24, 2025

Edimakor V4.0.0 Launches with AI Singing Photos & AI Animation

May 24, 2025

French taxi drivers threaten airports, French Open tennis in standoff

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia